anisometropia/atropine

OBJECTIVE To investigate the safety and efficacy of the treatment of myopic anisometropia with 1% atropine. METHODS Twenty-two children with myopic anisometropia were prescribed 1% solution of atropine sulfate to the more myopic eye, one drop before sleep every 3 days. Children were visited every 3

The pathogenesis of myopia and the mechanism of atropine in preventing myopic progression have long been widely discussed. Recent studies with animals have pointed to the possible role of the muscarinic receptor of the retina itself in regulating eye growth. This paper stresses that, for myopia in

BACKGROUND Some children have residual amblyopia after treatment with atropine eyedrops for amblyopia due to strabismus and/or anisometropia. We conducted a randomized clinical trial to evaluate the effectiveness of augmenting the effect of atropine by changing the lens over the fellow eye to plano

OBJECTIVE To determine the effectiveness of weekend atropine for severe amblyopia from strabismus, anisometropia, or both combined among children 3 to 12 years of age. METHODS We enrolled children into 2 prospective, randomized multicenter clinical trials of amblyopia therapy. Herein we report the

Myopic anisometropia (anisomyopia) is a specific type of refractive error that may cause fusion impairment, asthenopia, and aniseikonia. It is sometimes severe enough to reduce the quality of life. Several studies have investigated the treatment effects of orthokeratology (Ortho-K) and topical

The refractions of 1648 children aged 11 to 13 months are reported. Atropine 1% was used for cycloplegia. 11.83% of the children had bilateral hypermetropia of +2.00 or more D. 13.23% of them had +1.50 or more D astigmatism in one or both eyes, and 6.5% had anisometropia. Anisometropia was

OBJECTIVE To compare daily atropine to weekend atropine as prescribed treatments for moderate amblyopia in children younger than 7 years. METHODS Prospective, randomized multicenter clinical trial (30 sites). METHODS One hundred sixty-eight children younger than 7 years with amblyopia in the range

Purpose: To report the 1-year results of an investigation into whether there is an additive effect between 0.01% atropine and orthokeratology (ortho-k), in a single-masked, two-arm, randomised controlled trial: Combined Atropine with

The effects of accommodation demand and deprivation on the development of ocular optics was investigated in four groups of kittens (total n = 29). Group 1 consisted of five normal kittens; group 2 (nine kittens) had monocular radial keratotomy to induce relative hypermetropia and more accommodation

Retinoscopy was performed in 205 children under atropine cycloplegia during the first year of life. In 22% an astigmatism (minimum 1.0 D) was found with a small peak of incidence between the 31st and 40th week. In a follow-up study (45 children) the incidence and degree of astigmatism were found to

Recent studies suggest that children with amblyopia associated with anisometropia, strabismus, or both should be treated initially with best refractive correction until visual acuity is stable. This may take several months, and a proportion of children will achieve equal visual acuity with glasses

OBJECTIVE We sought to assess the success of amblyopia treatment in patients with small posterior lens opacities as well as the factors associated with a good visual outcome. METHODS This was a retrospective study of patients with posterior lens opacities that initially were thought to be too small

BACKGROUND Posterior polymorphous corneal dystrophy (PPCD) is typically considered bilateral and asymptomatic. However, few case reports on patients with unilateral PPCD with asymmetric refractive error have mentioned anisometropic amblyopia development. In support of this, we report 3 cases of

OBJECTIVE The aim of this study is to investigate the importance of occlusion therapy for amblyopia in patients with partial unilateral congenital cataracts that were discovered after 24 months of age. METHODS A retrospective study was conducted on 11 patients, each of whom underwent a clinical

OBJECTIVE To describe the demographic and clinical characteristics of a cohort of children with moderate amblyopia participating in the Amblyopia Treatment Study 1, a randomized trial comparing atropine and patching. METHODS The children enrolled were younger than 7 years and had strabismic,